000			01163 a2200349 4500
005			20250512075844.0
264		0	_c19851011
008			198510s 0 0 eng d
022			_a0252-9564
040			_aNLM _beng _cNLM
100	1		_aWeiss, P
245	0	0	_aSafety of thymopentin. Data from European clinical studies. _h[electronic resource]
260			_bSurvey of immunologic research _c1985
300			_a149-54 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article
650	0	4	_aAnimals
650	0	4	_aAnti-Inflammatory Agents _xadverse effects
650	0	4	_aArthritis, Rheumatoid _xdrug therapy
650	0	4	_aClinical Trials as Topic
650	0	4	_aDrug Tolerance
650	0	4	_aHumans
650	0	4	_aPeptide Fragments _xadverse effects
650	0	4	_aRabbits
650	0	4	_aSafety
650	0	4	_aSkin _xdrug effects
650	0	4	_aSleep Wake Disorders _xchemically induced
650	0	4	_aThymopentin
650	0	4	_aThymopoietins _xadverse effects
650	0	4	_aThymus Hormones _xadverse effects
700	1		_aStocker, H
773	0		_tSurvey of immunologic research _gvol. 4 Suppl 1 _gp. 149-54
999			_c3903978 _d3903978